(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure...
Stats | |
---|---|
Today's Volume | 455 985 |
Average Volume | 442 928 |
Market Cap | 11.47B |
EPS | $0 ( 2024-02-20 ) |
Next earnings date | ( $0.240 ) 2024-05-14 |
Last Dividend | $0.618 ( 2023-05-17 ) |
Next Dividend | $0 ( N/A ) |
P/E | 21.71 |
ATR14 | $0.0110 (0.06%) |
Volume Correlation
Fresenius Medical Care AG Correlation
10 Most Positive Correlations | |
---|---|
DMYS | 0.973 |
CXAC | 0.97 |
ALCC | 0.962 |
AFTR | 0.96 |
BMAC | 0.96 |
MTVC | 0.959 |
MTH | 0.959 |
TRCA | 0.958 |
BSAQ | 0.957 |
PNTM | 0.957 |
10 Most Negative Correlations | |
---|---|
GRUB | -0.954 |
PAK | -0.953 |
CCOR | -0.94 |
UNL | -0.936 |
TPL | -0.936 |
DBMF | -0.933 |
RSF | -0.931 |
UNG | -0.931 |
GAZ | -0.931 |
RKLY | -0.93 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fresenius Medical Care AG Correlation - Currency/Commodity
Fresenius Medical Care AG Financials
Annual | 2023 |
Revenue: | $19.45B |
Gross Profit: | $4.93B (25.32 %) |
EPS: | $1.700 |
Q4 | 2023 |
Revenue: | $4.99B |
Gross Profit: | $1.35B (27.06 %) |
EPS: | $0.640 |
Q3 | 2023 |
Revenue: | $4.94B |
Gross Profit: | $1.23B (24.90 %) |
EPS: | $0.290 |
Q2 | 2023 |
Revenue: | $4.83B |
Gross Profit: | $1.20B (24.81 %) |
EPS: | $0.480 |
Financial Reports:
No articles found.
Fresenius Medical Care AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.618 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0930 | 1998-06-08 |
Last Dividend | $0.618 | 2023-05-17 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-01 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | $10.47 | -- |
Avg. Dividend % Per Year | 1.85% | -- |
Score | 4.12 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.96 | |
Div. Directional Score | 8.70 | -- |
Year | Amount | Yield |
---|---|---|
1998 | $0.0930 | 0.85% |
1999 | $0.104 | 0.86% |
2000 | $0.111 | 0.80% |
2001 | $0.121 | 0.87% |
2002 | $0.125 | 1.21% |
2003 | $0.168 | 2.48% |
2004 | $0.253 | 2.11% |
2005 | $0.239 | 1.79% |
2006 | $0.244 | 1.35% |
2007 | $0.314 | 1.39% |
2008 | $0.416 | 1.58% |
2009 | $0.375 | 1.57% |
2010 | $0.408 | 1.50% |
2011 | $0.475 | 1.65% |
2012 | $0.456 | 1.30% |
2013 | $0.490 | 1.43% |
2014 | $0.533 | 1.53% |
2015 | $0.438 | 1.20% |
2016 | $0.440 | 1.07% |
2017 | $0.514 | 1.21% |
2018 | $0.632 | 1.21% |
2019 | $0.655 | 2.01% |
2020 | $0.707 | 1.91% |
2021 | $0.834 | 1.96% |
2022 | $0.709 | 2.17% |
2023 | $0.618 | 3.84% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0281 | 1.500 | 9.44 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0161 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0398 | 1.500 | -0.669 | -1.004 | [0.1 - 1] |
payoutRatioTTM | 0.601 | -1.000 | 3.99 | -3.99 | [0 - 1] |
currentRatioTTM | 1.424 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.916 | 0.800 | 9.32 | 7.45 | [0.8 - 2.5] |
cashRatioTTM | 0.230 | 1.500 | 9.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.355 | -1.500 | 4.08 | -6.12 | [0 - 0.6] |
interestCoverageTTM | 3.47 | 1.000 | 9.83 | 9.83 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 6.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.885 | -1.500 | 6.46 | -9.69 | [0 - 2.5] |
grossProfitMarginTTM | 0.253 | 1.000 | 9.11 | 9.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0710 | 1.000 | -0.580 | -0.580 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.218 | 1.000 | 9.90 | 9.90 | [0.2 - 2] |
assetTurnoverTTM | 0.573 | 0.800 | 9.51 | 7.61 | [0.5 - 2] |
Total Score | 11.44 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.53 | 1.000 | 9.14 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0398 | 2.50 | -0.430 | -1.004 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 7.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.48 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.601 | 1.500 | 3.99 | -3.99 | [0 - 1] |
pegRatioTTM | 1.352 | 1.500 | 4.32 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.135 | 1.000 | 9.12 | 0 | [0.1 - 0.5] |
Total Score | 5.96 |
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators